Marleen M van Dijk
Overview
Explore the profile of Marleen M van Dijk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
71
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kuiper S, Ploeger M, Wilms E, van Dijk M, Leegwater E, Huis Int Veld R, et al.
Antibiotics (Basel)
. 2022 Jan;
11(1).
PMID: 35052960
Chronic bacterial prostatitis is increasingly difficult to treat due to rising antimicrobial resistance limiting oral treatment options. In this case series, 11 men with CBP (including patients with urological comorbidities)...
2.
van Dijk M, Wijkstra H, Debruyne F, de la Rosette J, Michel M
BJU Int
. 2012 Feb;
105(8):1141-6.
PMID: 22299137
Objectives: To determine the role of treatment-associated improvement in nocturia in health-related quality of life (HRQL) in patients with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia, and...
3.
Sountoulides P, van Dijk M, Wijkstra H, de la Rosette J, Michel M
World J Urol
. 2009 Oct;
28(1):3-8.
PMID: 19816692
Purpose: Previous studies on associations between voiding dysfunction and quality of life (QoL) have largely been limited to baseline data. Therefore, we have explored associations between Q (max) and voiding...
4.
Kummerlin I, Borrego J, Wink M, van Dijk M, Wijkstra H, de la Rosette J, et al.
J Endourol
. 2007 Aug;
21(7):709-13.
PMID: 17705755
Background And Purpose: On the one hand, nephron-sparing surgery (NSS) in small renal tumors is a safe and effective alternative to radical nephrectomy. On the other hand, the role of...
5.
van Dijk M, de la Rosette J, Michel M
Drugs
. 2006 Mar;
66(3):287-301.
PMID: 16526818
alpha(1)-Adrenoceptor antagonists such as alfuzosin, doxazosin, tamsulosin and terazosin are first-line agents for the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (BPH), but are only second-line...
6.
van Dijk M, Mochtar C, Wijkstra H, Laguna M, de la Rosette J
Urology
. 2005 Oct;
66(4):845-9.
PMID: 16230150
Objectives: To assess the efficacy and safety of the thermoexpandable hourglass-shaped nitinol prostatic stent in the treatment of patients with lower urinary tract symptoms due to bladder outlet obstruction. Methods:...